Financial reports
10-K
2023 FY
Annual report
8 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
1 Aug 23
10-Q
2023 Q1
Quarterly report
2 May 23
10-K
2022 FY
Annual report
1 Mar 23
10-Q
2022 Q3
Quarterly report
1 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
3 Mar 22
10-Q
2021 Q3
Quarterly report
4 Nov 21
Current reports
8-K
2024 Investor Presentation www.OrthoPediatrics.com
11 Mar 24
8-K
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results
6 Mar 24
8-K
Results of Operations and Financial Condition
8 Jan 24
8-K
OrthoPediatrics Corp. Announces Acquisition of Boston OrthoticsĀ & Prosthetics
8 Jan 24
8-K
Entry into a Material Definitive Agreement
2 Jan 24
8-K
2023 Investor Presentation www.OrthoPediatrics.com
13 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
8 Nov 23
8-K/A
Submission of Matters to a Vote of Security Holders
8 Nov 23
8-K
OrthoPediatrics Corp. Reports Third Quarter 2023 Financial Results
6 Nov 23
8-K
2023 Investor Presentation www.OrthoPediatrics.com
7 Aug 23
Registration and prospectus
S-3
Shelf registration
15 Mar 24
424B5
Prospectus supplement for primary offering
12 Aug 22
S-3MEF
Registration of additional securities for an S-3
10 Aug 22
424B5
Prospectus supplement for primary offering
10 Aug 22
424B5
Prospectus supplement for primary offering
18 Jun 20
424B5
Prospectus supplement for primary offering
17 Jun 20
S-3
Shelf registration
13 Mar 20
424B5
Prospectus supplement for primary offering
12 Dec 19
S-3MEF
Registration of additional securities for an S-3
11 Dec 19
424B5
Prospectus supplement for primary offering
11 Dec 19
Proxies
DEFA14A
Additional proxy soliciting materials
8 Apr 24
DEF 14A
Definitive proxy
8 Apr 24
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
15 Apr 22
DEF 14A
Definitive proxy
15 Apr 22
DEFA14A
Additional proxy soliciting materials
16 Apr 21
DEF 14A
Definitive proxy
16 Apr 21
DEFA14A
Additional proxy soliciting materials
17 Apr 20
DEF 14A
Definitive proxy
17 Apr 20
Other
EFFECT
Notice of effectiveness
22 Apr 24
EFFECT
Notice of effectiveness
30 Mar 20
CORRESP
Correspondence with SEC
25 Mar 20
UPLOAD
Letter from SEC
23 Mar 20
UPLOAD
Letter from SEC
11 Jun 19
CORRESP
Correspondence with SEC
30 May 19
UPLOAD
Letter from SEC
15 May 19
EFFECT
Notice of effectiveness
9 Nov 18
CORRESP
Correspondence with SEC
7 Nov 18
UPLOAD
Letter from SEC
6 Nov 18
Ownership
4
David R Bailey
12 Mar 24
4
Daniel J Gerritzen
12 Mar 24
4
Gregory A Odle
12 Mar 24
4
Mark C Throdahl
12 Mar 24
4
Fred Hite
12 Mar 24
4
Joseph W Hauser
23 Feb 24
SC 13G/A
BROWN CAPITAL MANAGEMENT LLC
14 Feb 24
SC 13G/A
BROWN ADVISORY INC
9 Feb 24
SC 13G
BlackRock Inc.
31 Jan 24
4
David R Bailey
23 Jan 24